| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |